The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
Recruiting · NCT03747588 · Interventional (participants receive a specific treatment) · Lead sponsor: Peking Union Medical College Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Minimally-invasive pancreaticoduodenectomyOpen pancreaticoduodenectomy
What this trial is about
Minimally invasive pancreaticoduodenectomy remains one of the most challenging abdominal procedures. Safety and feasibility remain controversial when comparing minimally-invasive with open pancreaticoduodenectomy, especially for malignant tumors.The aim of this study was to compare minimally invasive and open pancreatoduodenectomy for short-term outcomes and long-term follow-up in a randomized trial.
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age: \>18yr, \<75yr
- Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy
- Preoperative imaging assessment is resectable or borderline resectable
Exclusion criteria
- Benign tumors of the head of pancreas
- Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis.
- conversion to laparotomy because of intraoperative difficulty
Where it is running
1 location listed.
- Chinese Academy of Medical Sciences & Peking Union Medical College Hospital - Beijing, Beijing Municipality, China